1, and Rui gene, the full name of Fujian and Rui gene science and technology limited company, is a focus on the whole disease process of the tumor genetic testing company. HeRui has established a complete genetic testing product service system for high-risk groups and patients, including tumor genetic susceptibility analysis, early screening, targeted and immune drug testing, efficacy monitoring, prognosis judgment and other series of products. In the field of early screening and diagnosis of tumors, Harmonic has initiated a series of clinical research projects on early warning screening for liver cancer, lung cancer, gynecological tumors and other tumors.
2. Based on the domestic NGS testing platform, JIINGA develops a series of clinical testing products for tumor and infectious diseases. It is mainly dedicated to promoting the application of high-throughput genetic testing technology in the field of tumor prevention and treatment, including precise medication guidance, efficacy monitoring, risk prediction and early detection of tumors, and is a pioneer in the field of tumor precision medicine.